<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35399702</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2590-0285</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Matrix biology plus</Title>
          <ISOAbbreviation>Matrix Biol Plus</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Modeling the mechanical stiffness of pancreatic ductal adenocarcinoma.</ArticleTitle>
        <Pagination>
          <StartPage>100109</StartPage>
          <MedlinePgn>100109</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">100109</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mbplus.2022.100109</ELocationID>
        <Abstract>
          <AbstractText>Despite improvements in the understanding of disease biology, pancreatic ductal adenocarcinoma (PDAC) remains the most malignant cancer of the pancreas. PDAC constitutes ∼95% of all pancreatic cancers, and it is highly resistant to therapeutics. The increased tissue rigidity, which stems from the rich fibrotic stroma in the tumor microenvironment, is central to disease development, physiology, and resistance to drug perfusion. Pancreatic stellate cells (PSCs) are responsible for overproduction of extracellular matrix in the fibrotic stroma, and this is exacerbated by the overexpression of transforming growth factor-β (TGF-β). However, there are few <i>in vitro</i> PDAC models, which include both PSCs and TGF-β or mimic <i>in vivo</i>-like tumor stiffness. In this study, we present a three-dimensional <i>in vitro</i> PDAC model, which includes PSCs and TGF-β, and recapitulates PDAC tissue mechanical stiffness. Using oscillatory shear rheology, we show the mechanical stiffness of the model is within range of the PDAC tissue stiffness by day 21 of culture and highlight that the matrix environment is essential to adequately capture PDAC disease. PDAC is a complex, aggressive disease with poor prognosis, and biophysically relevant <i>in vitro</i> PDAC models, which take into account tissue mechanics, will provide improved tumor models for effective therapeutic assessment.</AbstractText>
          <CopyrightInformation>Crown Copyright © 2022 Published by Elsevier B.V.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kpeglo</LastName>
            <ForeName>Delanyo</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, LS2 9 JT, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hughes</LastName>
            <ForeName>Matthew D G</ForeName>
            <Initials>MDG</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, LS2 9 JT, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Astbury Centre for Structural Molecular Biology, University of Leeds, LS2 9JT, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dougan</LastName>
            <ForeName>Lorna</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, LS2 9 JT, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Astbury Centre for Structural Molecular Biology, University of Leeds, LS2 9JT, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haddrick</LastName>
            <ForeName>Malcolm</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Medicines Discovery Catapult, Block 35, Mereside Alderley Park, Alderley Edge, SK10 4TG, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Knowles</LastName>
            <ForeName>Margaret A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Leeds Institute of Medical Research at St James's (LIMR), School of Medicine, University of Leeds, LS2 9 JT, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Evans</LastName>
            <ForeName>Stephen D</ForeName>
            <Initials>SD</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, LS2 9 JT, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Astbury Centre for Structural Molecular Biology, University of Leeds, LS2 9JT, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peyman</LastName>
            <ForeName>Sally A</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, LS2 9 JT, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Leeds Institute of Medical Research at St James's (LIMR), School of Medicine, University of Leeds, LS2 9 JT, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Matrix Biol Plus</MedlineTA>
        <NlmUniqueID>101775320</NlmUniqueID>
        <ISSNLinking>2590-0285</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Oscillatory shear rheology</Keyword>
        <Keyword MajorTopicYN="N">Pancreatic ductal adenocarcinoma</Keyword>
        <Keyword MajorTopicYN="N">Pancreatic stellate cells</Keyword>
        <Keyword MajorTopicYN="N">Tissue mechanics</Keyword>
        <Keyword MajorTopicYN="N">Transforming growth factor β1</Keyword>
        <Keyword MajorTopicYN="N">Tumor microenvironment</Keyword>
        <Keyword MajorTopicYN="N">Tumour biophysics</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>11</Day>
          <Hour>5</Hour>
          <Minute>16</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35399702</ArticleId>
        <ArticleId IdType="pmc">PMC8990173</ArticleId>
        <ArticleId IdType="doi">10.1016/j.mbplus.2022.100109</ArticleId>
        <ArticleId IdType="pii">S2590-0285(22)00009-6</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bond-Smith G., Banga N., Hammond T.M., Imber C.J. Pancreatic adenocarcinoma. BMJ. 2012;344</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22592847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dimastromatteo J., Houghton J.L., Lewis J.S., Kelly K.A. Challenges of pancreatic cancer. Cancer J. 2015;21(3):188–193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4517183</ArticleId>
            <ArticleId IdType="pubmed">26049698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piersma B., Hayward M.K., Weaver V.M. Fibrosis and cancer: A strained relationship. Biochim. Biophys. Acta, Rev. Cancer. 2020;1873(2)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7733542</ArticleId>
            <ArticleId IdType="pubmed">32147542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rawla P., Sunkara T., Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J. Oncol. 2019;10(1):10–27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6396775</ArticleId>
            <ArticleId IdType="pubmed">30834048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adamska A., Domenichini A., Falasca M. Pancreatic ductal adenocarcinoma: current and evolving therapies. Int. J. Mol. Sci. 2017;18(7):1338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5535831</ArticleId>
            <ArticleId IdType="pubmed">28640192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feig C., Gopinathan A., Neesse A., Chan D.S., Cook N., Tuveson D.A. The pancreas cancer microenvironment. Clin. Cancer Res. 2012;18(16):4266–4276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3442232</ArticleId>
            <ArticleId IdType="pubmed">22896693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Güngör C., Hofmann B.T., Wolters-Eisfeld G., Bockhorn M. Pancreatic cancer. Br. J. Pharmacol. 2014;171(4):849–858.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3925023</ArticleId>
            <ArticleId IdType="pubmed">24024905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mekapogu, A.R., Pothula, S.P., Pirola, R.C., Wilson, J.S. and Apte, M.V. Multifunctional role of pancreatic stellate cells in pancreatic cancer. Ann. Pancr. Cancer. (2019) 2, pp.10-10.</Citation>
        </Reference>
        <Reference>
          <Citation>Weniger, M., Honselmann, K.C. and Liss, A.S. The Extracellular Matrix and Pancreatic Cancer: A Complex Relationship. Cancers (Basel). (2018) 10(9).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6162452</ArticleId>
            <ArticleId IdType="pubmed">30200666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apte M.V., Pirola R.C., Wilson J.S. Pancreatic stellate cells: a starring role in normal and diseased pancreas. Front. Physiol. 2012;3:344.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3428781</ArticleId>
            <ArticleId IdType="pubmed">22973234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frantz C., Stewart K.M., Weaver V.M. The extracellular matrix at a glance. J. Cell Sci. 2010;123(Pt 24):4195–4200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2995612</ArticleId>
            <ArticleId IdType="pubmed">21123617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pothula S.P., Pirola R.C., Wilson J.S., Apte M.V. Pancreatic stellate cells: Aiding and abetting pancreatic cancer progression. Pancreatology. 2020;20(3):409–418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31928917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin G., Hong W., Guo Y., Bai Y., Chen B. Molecular mechanism of pancreatic stellate cells activation in chronic pancreatitis and pancreatic cancer. J Cancer. 2020;11(6):1505–1515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6995390</ArticleId>
            <ArticleId IdType="pubmed">32047557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohlund D., Handly-Santana A., Biffi G., Elyada E., Almeida A.S., Ponz-Sarvise M., Corbo V., Oni T.E., Hearn S.A., Lee E.J., Chio I.I., Hwang C.I., Tiriac H., Baker L.A., Engle D.D., Feig C., Kultti A., Egeblad M., Fearon D.T., Crawford J.M., Clevers H., Park Y., Tuveson D.A. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J. Exp. Med. 2017;214(3):579–596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5339682</ArticleId>
            <ArticleId IdType="pubmed">28232471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xue R., Jia K., Wang J., Yang L., Wang Y., Gao L., Hao J. A rising star in pancreatic diseases: pancreatic stellate cells. Front. Physiol. 2018;9:754.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6015921</ArticleId>
            <ArticleId IdType="pubmed">29967585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bolm L., Cigolla S., Wittel U.A., Hopt U.T., Keck T., Rades D., Bronsert P., Wellner U.F. The role of fibroblasts in pancreatic cancer: extracellular matrix versus paracrine factors. Transl. Oncol. 2017;10(4):578–588.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5487255</ArticleId>
            <ArticleId IdType="pubmed">28658650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dufort C.C., DelGiorno K.E., Carlson M.A., Osgood R.J., Zhao C., Huang Z., Thompson C.B., Connor R.J., Thanos C.D., Brockenbrough J.S., Provenzano P.P., Frost G.I., Shepard H.M., Hingorani S.R. Interstitial pressure in pancreatic ductal adenocarcinoma is dominated by a gel-fluid phase. Biophys. J. 2016;110(9):2106–2119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4939548</ArticleId>
            <ArticleId IdType="pubmed">27166818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferdek P.E., Jakubowska M.A. Biology of pancreatic stellate cells-more than just pancreatic cancer. Pflugers Arch. 2017;469(9):1039–1050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5554282</ArticleId>
            <ArticleId IdType="pubmed">28382480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hosein A.N., Brekken R.A., Maitra A. Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat. Rev. Gastroenterol. Hepatol. 2020;17(8):487–505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8284850</ArticleId>
            <ArticleId IdType="pubmed">32393771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orth M., Metzger P., Gerum S., Mayerle J., Schneider G., Belka C., Schnurr M., Lauber K. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiat. Oncol. 2019;14(1):141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6688256</ArticleId>
            <ArticleId IdType="pubmed">31395068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phillips, P. Pancreatic stellate cells and fibrosis. In: Grippo, P.J. and Munshi, H.G. eds. Pancreatic Cancer and Tumor Microenvironment. (2012).</Citation>
        </Reference>
        <Reference>
          <Citation>Robinson B.K., Cortes E., Rice A.J., Sarper M., Del Rio Hernandez A. Quantitative analysis of 3D extracellular matrix remodelling by pancreatic stellate cells. Biol Open. 2016;5(6):875–882.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4920190</ArticleId>
            <ArticleId IdType="pubmed">27170254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rice A.J., Cortes E., Lachowski D., Cheung B.C.H., Karim S.A., Morton J.P., Del Rio Hernandez A. Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells. Oncogenesis. 2017;6(7)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5541706</ArticleId>
            <ArticleId IdType="pubmed">28671675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stylianopoulos T., Munn L.L., Jain R.K. Reengineering the physical microenvironment of tumors to improve drug delivery and efficacy: from mathematical modeling to bench to bedside. Trends Cancer. 2018;4(4):292–319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5930008</ArticleId>
            <ArticleId IdType="pubmed">29606314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain R.K., Martin J.D., Stylianopoulos T. The role of mechanical forces in tumor growth and therapy. Annu. Rev. Biomed. Eng. 2014;16:321–346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4109025</ArticleId>
            <ArticleId IdType="pubmed">25014786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wullkopf L., West A.V., Leijnse N., Cox T.R., Madsen C.D., Oddershede L.B., Erler J.T. Cancer cells' ability to mechanically adjust to extracellular matrix stiffness correlates with their invasive potential. Mol. Biol. Cell. 2018;29(20):2378–2385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6233061</ArticleId>
            <ArticleId IdType="pubmed">30091653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu T., Zhou L., Li D., Andl T., Zhang Y. Cancer-associated fibroblasts build and secure the tumor microenvironment. Front. Cell Dev. Biol. 2019;7:60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6492564</ArticleId>
            <ArticleId IdType="pubmed">31106200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stylianopoulos T., Martin J.D., Chauhan V.P., Jain S.R., Diop-Frimpong B., Bardeesy N., Smith B.L., Ferrone C.R., Hornicek F.J., Boucher Y., Munn L.L., Jain R.K. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc. Natl. Acad. Sci. U S A. 2012;109(38):15101–15108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3458380</ArticleId>
            <ArticleId IdType="pubmed">22932871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen A.V., Nyberg K.D., Scott M.B., Welsh A.M., Nguyen A.H., Wu N., Hohlbauch S.V., Geisse N.A., Gibb E.A., Robertson A.G., Donahue T.R., Rowat A.C. Stiffness of pancreatic cancer cells is associated with increased invasive potential. Integr. Biol. (Camb) 2016;8(12):1232–1245.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5866717</ArticleId>
            <ArticleId IdType="pubmed">27761545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Payen T., Oberstein P., Saharkhiz N., Palermo C., Sastra S., Han Y., Nabavizadeh A., Sagalovskiy I., Orelli B., Rosario V., Desrouilleres D., Remotti H., Kluger M., Schrope B., Chabot J., Iuga A., Konofagou E., Olive K. Harmonic motion imaging of pancreatic tumor stiffness indicates disease state and treatment response. Clin. Cancer Res. 2020;26(6):1297–1308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7073277</ArticleId>
            <ArticleId IdType="pubmed">31831559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubiano A., Delitto D., Han S., Gerber M., Galitz C., Trevino J., Thomas R.M., Hughes S.J., Simmons C.S. Viscoelastic properties of human pancreatic tumors and in vitro constructs to mimic mechanical properties. Acta Biomater. 2018;67:331–340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5797706</ArticleId>
            <ArticleId IdType="pubmed">29191507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wex C., Frohlich M., Brandstadter K., Bruns C., Stoll A. Experimental analysis of the mechanical behavior of the viscoelastic porcine pancreas and preliminary case study on the human pancreas. J. Mech. Behav. Biomed. Mater. 2015;41:199–207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25460416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lazzari G., Nicolas V., Matsusaki M., Akashi M., Couvreur P., Mura S. Multicellular spheroid based on a triple co-culture: A novel 3D model to mimic pancreatic tumor complexity. Acta Biomater. 2018;78:296–307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30099198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Longati P., Jia X., Eimer J., Wagman A., Witt M., Rehnmark S., Verbeke C., Toftgård R., Löhr M., Heuchel R.L. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer. 2013;13(13)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3617005</ArticleId>
            <ArticleId IdType="pubmed">23446043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ware M.J., Colbert K., Keshishian V., Ho J., Corr S.J., Curley S.A., Godin B. Generation of homogenous three-dimensional pancreatic cancer cell spheroids using an improved hanging drop technique. Tissue Eng. Part C Methods. 2016;22(4):312–321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4827286</ArticleId>
            <ArticleId IdType="pubmed">26830354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boj S.F., Hwang C.I., Baker L.A., Chio I.I., Engle D.D., Corbo V., Jager M., Ponz-Sarvise M., Tiriac H., Spector M.S., Gracanin A., Oni T., Yu K.H., van Boxtel R., Huch M., Rivera K.D., Wilson J.P., Feigin M.E., Ohlund D., Handly-Santana A., Ardito-Abraham C.M., Ludwig M., Elyada E., Alagesan B., Biffi G., Yordanov G.N., Delcuze B., Creighton B., Wright K., Park Y., Morsink F.H., Molenaar I.Q., Borel Rinkes I.H., Cuppen E., Hao Y., Jin Y., Nijman I.J., Iacobuzio-Donahue C., Leach S.D., Pappin D.J., Hammell M., Klimstra D.S., Basturk O., Hruban R.H., Offerhaus G.J., Vries R.G., Clevers H., Tuveson D.A. Organoid models of human and mouse ductal pancreatic cancer. Cell. 2015;160(1–2):324–338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4334572</ArticleId>
            <ArticleId IdType="pubmed">25557080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsai S., McOlash L., Palen K., Johnson B., Duris C., Yang Q., Dwinell M.B., Hunt B., Evans D.B., Gershan J., James M.A. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models. BMC Cancer. 2018;18(1):335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5870823</ArticleId>
            <ArticleId IdType="pubmed">29587663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ware M.J., Keshishian V., Law J.J., Ho J.C., Favela C.A., Rees P., Smith B., Mohammad S., Hwang R.F., Rajapakshe K., Coarfa C., Huang S., Edwards D.P., Corr S.J., Godin B., Curley S.A. Generation of an in vitro 3D PDAC stroma rich spheroid model. Biomaterials. 2016;108:129–142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5082237</ArticleId>
            <ArticleId IdType="pubmed">27627810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erkan M., Adler G., Apte M.V., Bachem M.G., Buchholz M., Detlefsen S., Esposito I., Friess H., Gress T.M., Habisch H., Hwang R.F., Jaster R., Kleeff J., Kloppel G., Kordes C., Logsdon C.D., Masamune A., Michalski C.W., Oh J., Phillips J.B., Pinzani M., Reiser-Erkan C., Tsukamoto H., Wilson J. StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut. 2012;61(2):172–178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3245897</ArticleId>
            <ArticleId IdType="pubmed">22115911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lachowski D., Cortes E., Pink D., Chronopoulos A., Karim S.A., J.P.M., Del Rio Hernandez A.E. Substrate rigidity controls activation and durotaxis in pancreatic stellate cells. Sci. Rep. 2017;7(1):2506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5451433</ArticleId>
            <ArticleId IdType="pubmed">28566691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stromnes I.M., DelGiorno K.E., Greenberg P.D., Hingorani S.R. Stromal reengineering to treat pancreas cancer. Carcinogenesis. 2014;35(7):1451–1460.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4076816</ArticleId>
            <ArticleId IdType="pubmed">24908682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burla F., Mulla Y., Vos B.E., Aufderhorst-Roberts A., Koenderink G.H. From mechanical resilience to active material properties in biopolymer networks. Nat. Rev. Phys. 2019;1(4):249–263.</Citation>
        </Reference>
        <Reference>
          <Citation>P.A. Janmey, P.C. Georges, S. Hvidt, Basic Rheology for Biologists. In: Methods in Cell Biology. (2007) pp.1, 3-27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17613302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weitz D., Wyss H.M., Larsen R.J. Oscillatory rheology measuring the viscoelastic behaviour of soft materials. GIT Lab. J. Europe. 2007;11:68–70.</Citation>
        </Reference>
        <Reference>
          <Citation>Costa E.C., Moreira A.F., de Melo-Diogo D., Gaspar V.M., Carvalho M.P., Correia I.J. 3D tumor spheroids: an overview on the tools and techniques used for their analysis. Biotechnol. Adv. 2016;34(8):1427–1441.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27845258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sutherland R.M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science. 1988;240(4849):177–184.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2451290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zanoni M., Piccinini F., Arienti C., Zamagni A., Santi S., Polico R., Bevilacqua A., Tesei A. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci. Rep. 2016;6:19103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4707510</ArticleId>
            <ArticleId IdType="pubmed">26752500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grasso C., Jansen G., Giovannetti E. Drug resistance in pancreatic cancer: Impact of altered energy metabolism. Crit. Rev. Oncol. Hematol. 2017;114:139–152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28477742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamasaki A., Yanai K., Onishi H. Hypoxia and pancreatic ductal adenocarcinoma. Cancer Lett. 2020;484:9–15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32380129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmed S., Bradshaw A.D., Gera S., Dewan M.Z., Xu R. The TGF-beta/Smad4 signaling pathway in pancreatic carcinogenesis and its clinical significance. J. Clin. Med. 2017;6(1)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5294958</ArticleId>
            <ArticleId IdType="pubmed">28067794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haeberle L., Steiger K., Schlitter A.M., Safi S.A., Knoefel W.T., Erkan M., Esposito I. Stromal heterogeneity in pancreatic cancer and chronic pancreatitis. Pancreatology. 2018;18(5):536–549.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29778400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haqq J., Howells L.M., Garcea G., Metcalfe M.S., Steward W.P., Dennison A.R. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies. Eur. J. Cancer. 2014;50(15):2570–2582.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25091797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu S.L., Cao S.G., Li Y., Sun B., Chen D., Wang D.S., Zhou Y.B. Pancreatic stellate cells facilitate pancreatic cancer cell viability and invasion. Oncol. Lett. 2019;17(2):2057–2062.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6341873</ArticleId>
            <ArticleId IdType="pubmed">30675272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schnittert J., Bansal R., Prakash J. Targeting pancreatic stellate cells in cancer. Trends Cancer. 2019;5(2):128–142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30755305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baumgart F. Stiffness — an unknown world of mechanical science? Injury. 2000;31:14–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10853758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antoine E.E., Vlachos P.P., Rylander M.N. Review of collagen I hydrogels for bioengineered tissue microenvironments: characterization of mechanics, structure, and transport. Tissue Eng. Part B Rev. 2014;20(6):683–696.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4241868</ArticleId>
            <ArticleId IdType="pubmed">24923709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gelse K., Poschl E., Aigner T. Collagens–structure, function, and biosynthesis. Adv. Drug Deliv. Rev. 2003;55(12):1531–1546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14623400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Provenzano P.P., Hingorani S.R. Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer. Br. J. Cancer. 2013;108(1):1–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3553539</ArticleId>
            <ArticleId IdType="pubmed">23299539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DuFort C.C., DelGiorno K.E., Hingorani S.R. Mounting pressure in the microenvironment: fluids, solids, and cells in pancreatic ductal adenocarcinoma. Gastroenterology. 2016;150(7):1545–1557 e1542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4957812</ArticleId>
            <ArticleId IdType="pubmed">27072672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abnaof K., Mallela N., Walenda G., Meurer S.K., Seré K., Lin Q., Smeets B., Hoffmann K., Wagner W., Zenke M., Weiskirchen R., Fröhlich H. TGF-β stimulation in human and murine cells reveals commonly affected biological processes and pathways at transcription level. BMC Syst. Biol. 2014;8(1):55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4049504</ArticleId>
            <ArticleId IdType="pubmed">24886091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lampi M.C., Reinhart-King C.A. Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials. Sci. Transl. Med. 2018;10(422)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29298864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papageorgis P., Stylianopoulos T. Role of TGFbeta in regulation of the tumor microenvironment and drug delivery (review) Int. J. Oncol. 2015;46(3):933–943.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4306018</ArticleId>
            <ArticleId IdType="pubmed">25573346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato N., Cheng X.B., Kohi S., Koga A., Hirata K. Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma. Acta Pharm. Sin. B. 2016;6(2):101–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4788704</ArticleId>
            <ArticleId IdType="pubmed">27006892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato N., Kohi S., Hirata K., Goggins M. Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight. Cancer Sci. 2016;107(5):569–575.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4970823</ArticleId>
            <ArticleId IdType="pubmed">26918382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonnans C., Chou J., Werb Z. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 2014;15(12):786–801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4316204</ArticleId>
            <ArticleId IdType="pubmed">25415508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muiznieks L.D., Keeley F.W. Molecular assembly and mechanical properties of the extracellular matrix: A fibrous protein perspective. Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids. 2013;1832(7):866–875.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23220448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papalazarou V., Salmeron-Sanchez M., Machesky L.M. Tissue engineering the cancer microenvironment-challenges and opportunities. Biophys. Rev. 2018;10(6):1695–1711.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6297082</ArticleId>
            <ArticleId IdType="pubmed">30406572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suresh S. Biomechanics and biophysics of cancer cells. Acta Biomater. 2007;3(4):413–438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2917191</ArticleId>
            <ArticleId IdType="pubmed">17540628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kechagia J.Z., Ivaska J., Roca-Cusachs P. Integrins as biomechanical sensors of the microenvironment. Nat. Rev. Mol. Cell Biol. 2019;20(8):457–473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31182865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Below C.R., Kelly J., Brown A., Humphries J.D., Hutton C., Xu J., Lee B.Y., Cintas C., Zhang X., Hernandez-Gordillo V., Stockdale L., Goldsworthy M.A., Geraghty J., Foster L., O’Reilly D.A., Schedding B., Askari J., Burns J., Hodson N., Smith D.L., Lally C., Ashton G., Knight D., Mironov A., Banyard A., Eble J.A., Morton J.P., Humphries M.J., Griffith L.G., Jørgensen C. A microenvironment-inspired synthetic three-dimensional model for pancreatic ductal adenocarcinoma organoids. Nat. Mater. 2022;21(1):110–119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7612137</ArticleId>
            <ArticleId IdType="pubmed">34518665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Sousa Cavalcante L., Monteiro G. Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer. Eur. J. Pharmacol. 2014;741:8–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25084222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mini E., Nobili S., Caciagli B., Landini I., Mazzei T. Cellular pharmacology of gemcitabine. Ann. Oncol. 2006;17(Suppl 5):v7–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16807468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alvarellos M.L., Lamba J., Sangkuhl K., Thorn C.F., Wang L., Klein D.J., Altman R.B., Klein T.E. PharmGKB summary: gemcitabine pathway. Pharmacogenet. Genomics. 2014;24(11):564–574.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4189987</ArticleId>
            <ArticleId IdType="pubmed">25162786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amrutkar M., Gladhaug I. Pancreatic cancer chemoresistance to gemcitabine. Cancers (Basel) 2017;9(12):157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5704175</ArticleId>
            <ArticleId IdType="pubmed">29144412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cox T.R. The matrix in cancer. Nat. Rev. Cancer. 2021;21(4):217–238.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33589810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DuFort C.C., DelGiorno K.E., Carlson M.A., Osgood R.J., Zhao C., Huang Z., Thompson C.B., Connor R.J., Thanos C.D., Scott Brockenbrough J., Provenzano P.P., Frost G.I., Michael Shepard H., Hingorani S.R. Interstitial pressure in pancreatic ductal adenocarcinoma is dominated by a gel-fluid phase. Biophys. J. 2016;110(9):2106–2119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4939548</ArticleId>
            <ArticleId IdType="pubmed">27166818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heldin C.H., Rubin K., Pietras K., Ostman A. High interstitial fluid pressure - an obstacle in cancer therapy. Nat. Rev. Cancer. 2004;4(10):806–813.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15510161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winkler J., Abisoye-Ogunniyan A., Metcalf K.J., Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat. Commun. 2020;11(1):5120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7547708</ArticleId>
            <ArticleId IdType="pubmed">33037194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daniel S.K., Sullivan K.M., Labadie K.P., Pillarisetty V.G. Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma. Clin. Transl. Med. 2019;8(1):10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6441665</ArticleId>
            <ArticleId IdType="pubmed">30931508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirakawa T., Yashiro M., Doi Y., Kinoshita H., Morisaki T., Fukuoka T., Hasegawa T., Kimura K., Amano R., Hirakawa K. Pancreatic fibroblasts stimulate the motility of pancreatic cancer cells through IGF1/IGF1R signaling under hypoxia. PLoS ONE. 2016;11(8)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4972430</ArticleId>
            <ArticleId IdType="pubmed">27487118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spivak-Kroizman T.R., Hostetter G., Posner R., Aziz M., Hu C., Demeure M.J., Von Hoff D., Hingorani S.R., Palculict T.B., Izzo J., Kiriakova G.M., Abdelmelek M., Bartholomeusz G., James B.P., Powis G. Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer. Cancer Res. 2013;73(11):3235–3247.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3782107</ArticleId>
            <ArticleId IdType="pubmed">23633488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao X., Gao S., Ren H., Sun W., Zhang H., Sun J., Yang S., Hao J. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. Cancer Res. 2014;74(9):2455–2464.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24599125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burroughs S.K., Kaluz S., Wang D., Wang K., Van Meir E.G., Wang B. Hypoxia inducible factor pathway inhibitors as anticancer therapeutics. Future Med. Chem. 2013;5(5):553–572.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3871878</ArticleId>
            <ArticleId IdType="pubmed">23573973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masoud G.N., Li W. HIF-1alpha pathway: role, regulation and intervention for cancer therapy. Acta Pharm. Sin. B. 2015;5(5):378–389.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4629436</ArticleId>
            <ArticleId IdType="pubmed">26579469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rohwer N., Cramer T. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resist. Updat. 2011;14(3):191–201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21466972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrova V., Annicchiarico-Petruzzelli M., Melino G., Amelio I. The hypoxic tumour microenvironment. Oncogenesis. 2018;7(1):10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5833859</ArticleId>
            <ArticleId IdType="pubmed">29362402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deer E.L., Gonzalez-Hernandez J., Coursen J.D., Shea J.E., Ngatia J., Scaife C.L., Firpo M.A., Mulvihill S.J. Phenotype and genotype of pancreatic cancer cell lines. Pancreas. 2010;39(4):425–435.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2860631</ArticleId>
            <ArticleId IdType="pubmed">20418756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujiwara M., Kanayama K., Hirokawa Y.S., Shiraishi T. ASF-4-1 fibroblast-rich culture increases chemoresistance and mTOR expression of pancreatic cancer BxPC-3 cells at the invasive front in vitro, and promotes tumor growth and invasion in vivo. Oncol Lett. 2016;11(4):2773–2779.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4812595</ArticleId>
            <ArticleId IdType="pubmed">27073551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W., Wong C., Vosburgh E., Levine A.J., Foran D.J., Xu E.Y. High-throughput image analysis of tumor spheroids: a user-friendly software application to measure the size of spheroids automatically and accurately. J Vis Exp. 2014:(89).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4212916</ArticleId>
            <ArticleId IdType="pubmed">25046278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang Y., Eglen R.M. Three-dimensional cell cultures in drug discovery and development. SLAS Discov.: Advan. Life Sci. R &amp; D. 2017;22(5):456–472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5448717</ArticleId>
            <ArticleId IdType="pubmed">28520521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frappart P.-O., Hofmann T.G. Pancreatic Ductal Adenocarcinoma (PDAC) organoids: the shining light at the end of the tunnel for drug response prediction and personalized medicine. Cancers (Basel) 2020;12(10):2750.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7598647</ArticleId>
            <ArticleId IdType="pubmed">32987786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin C.C., Korc M. Designer hydrogels: Shedding light on the physical chemistry of the pancreatic cancer microenvironment. Cancer Lett. 2018;436:22–27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6557435</ArticleId>
            <ArticleId IdType="pubmed">30118843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tibbitt M.W., Anseth K.S. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol. Bioeng. 2009;103(4):655–663.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2997742</ArticleId>
            <ArticleId IdType="pubmed">19472329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J., Li P., Dong C., Jiang H., Bin X., Gao X., Qin M., Wang W., Bin C., Cao Y. Rationally designed synthetic protein hydrogels with predictable mechanical properties. Nat. Commun. 2018;9(1):620.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5809592</ArticleId>
            <ArticleId IdType="pubmed">29434258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh V., Barbosa F.L., Torricelli A.A., Santhiago M.R., Wilson S.E. Transforming growth factor beta and platelet-derived growth factor modulation of myofibroblast development from corneal fibroblasts in vitro. Exp. Eye Res. 2014;120:152–160.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3943625</ArticleId>
            <ArticleId IdType="pubmed">24429028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tomlinson D.C., Freestone S.H., Grace O.C., Thomson A.A. Differential effects of transforming growth factor-beta1 on cellular proliferation in the developing prostate. Endocrinology. 2004;145(9):4292–4300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15192047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y., Khuu N., Prince E., Tao H., Zhang N., Chen Z., Gevorkian A., McGuigan A.P., Kumacheva E. Matrix stiffness-regulated growth of breast tumor spheroids and their response to chemotherapy. Biomacromolecules. 2021;22(2):419–429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33136364</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
